Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial
- Resource Type
- Article
- Source
- In
Vaccine 14 March 2014 32(13):1480-1487 - Subject
- Language
- ISSN
- 0264-410X